The Role of Pharmacogenomics in Personalized Drug Therapy

Pharmacogenomics is one of the significant new developments in the area of precision medicine, integrating genetic science with pharmacology to tailor drug therapy to individual genetic profiles to the maximum. The study examines the basics, usage, and future prospects of pharmacogenomics in the customization of therapy in different aspects of medicine. It provides an explanation of the role of genetic variations affecting drug response, integration of pharmacogenomic testing into clinical practice and the development of targeted therapies, especially in oncology and cardiovascular medicine. Another issue that the paper discusses is the role of pharmacogenomics in minimizing adverse drug reactions, enhancing drug development, and facilitating cost-effective healthcare. Ethical issues, legal issues, and social issues are discussed, together with the emerging technologies, with artificial intelligence, which are transforming the interpretation of genomic data and clinical decisions. The conclusions underscore the fact that pharmacogenomics is not just a scientific breakthrough, but also a revolution to safer, more efficient and patient-centered healthcare.